P

Pharmaniaga Bhd
KLSE:PHARMA

Watchlist Manager
Pharmaniaga Bhd
KLSE:PHARMA
Watchlist
Price: 0.36 MYR -1.37%
Market Cap: 518.8m MYR
Have any thoughts about
Pharmaniaga Bhd?
Write Note

Pharmaniaga Bhd
Cost of Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Pharmaniaga Bhd
Cost of Revenue Peer Comparison

Comparables:
ATPC
U
UMC

Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors

Company Cost of Revenue CAGR 3Y CAGR 5Y CAGR 10Y
P
Pharmaniaga Bhd
KLSE:PHARMA
Cost of Revenue
-myr3.2B
CAGR 3-Years
-3%
CAGR 5-Years
-7%
CAGR 10-Years
-6%
Agape ATP Corp
NASDAQ:ATPC
Cost of Revenue
-$492.3k
CAGR 3-Years
-5%
CAGR 5-Years
19%
CAGR 10-Years
N/A
U
UMediC Group Bhd
KLSE:UMC
Cost of Revenue
-myr31.9m
CAGR 3-Years
-14%
CAGR 5-Years
-24%
CAGR 10-Years
N/A

See Also

What is Pharmaniaga Bhd's Cost of Revenue?
Cost of Revenue
-3.2B MYR

Based on the financial report for Jun 30, 2024, Pharmaniaga Bhd's Cost of Revenue amounts to -3.2B MYR.

What is Pharmaniaga Bhd's Cost of Revenue growth rate?
Cost of Revenue CAGR 10Y
-6%

Over the last year, the Cost of Revenue growth was 0%. The average annual Cost of Revenue growth rates for Pharmaniaga Bhd have been -3% over the past three years , -7% over the past five years , and -6% over the past ten years .

Back to Top